These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21383697)

  • 1. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.
    Oneyama C; Ikeda J; Okuzaki D; Suzuki K; Kanou T; Shintani Y; Morii E; Okumura M; Aozasa K; Okada M
    Oncogene; 2011 Aug; 30(32):3489-501. PubMed ID: 21383697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression.
    Oneyama C; Morii E; Okuzaki D; Takahashi Y; Ikeda J; Wakabayashi N; Akamatsu H; Tsujimoto M; Nishida T; Aozasa K; Okada M
    Oncogene; 2012 Mar; 31(13):1623-35. PubMed ID: 21860426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
    Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
    Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
    Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
    Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate.
    Lee JY; Chang JW; Yang WS; Kim SB; Park SK; Park JS; Lee SK
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1214-22. PubMed ID: 21367918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.
    Li X; Shen Y; Ichikawa H; Antes T; Goldberg GS
    Oncogene; 2009 Dec; 28(48):4272-83. PubMed ID: 19767772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells.
    Jiang H; Qu L; Wang Y; Cong J; Wang W; Yang X
    Biomed Pharmacother; 2014 Mar; 68(2):163-9. PubMed ID: 24456664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
    He H; Hirokawa Y; Levitzki A; Maruta H
    Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.
    Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y
    Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
    Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR.
    Yin H; Ma J; Chen L; Piao S; Zhang Y; Zhang S; Ma H; Li Y; Qu Y; Wang X; Xu Q
    Cell Physiol Biochem; 2018; 46(2):471-481. PubMed ID: 29614485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
    Hu Y; Zhu Q; Tang L
    PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer.
    Huang HG; Luo X; Wu S; Jian B
    Asian Pac J Cancer Prev; 2015; 16(12):4937-44. PubMed ID: 26163618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.